Your browser doesn't support javascript.
loading
JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells.
Eschweiler, Simon; Wang, Alice; Ramírez-Suástegui, Ciro; von Witzleben, Adrian; Li, Yingcong; Chee, Serena J; Simon, Hayley; Mondal, Monalisa; Ellis, Matthew; Thomas, Gareth J; Chandra, Vivek; Ottensmeier, Christian H; Vijayanand, Pandurangan.
Afiliación
  • Eschweiler S; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Wang A; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Ramírez-Suástegui C; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • von Witzleben A; Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
  • Li Y; La Jolla Institute for Immunology, La Jolla, CA, USA; University of California San Diego, La Jolla, CA, USA.
  • Chee SJ; Department of Molecular and Clinical Cancer Medicine and NIHR and CRUK Liverpool Experimental Cancer Medicine Center, University of Liverpool, Liverpool, UK; Department of Respiratory Medicine, Liverpool Heart and Chest Hospital and NHS Foundation Trust, Liverpool, UK.
  • Simon H; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Mondal M; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Ellis M; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK; NIHR Southampton Biomedical Research Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Thomas GJ; NIHR and CRUK Southampton Experimental Cancer Medicine Center, Faculty of Medicine, University of Southampton, Southampton, UK; NIHR Southampton Biomedical Research Center, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Chandra V; La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Ottensmeier CH; La Jolla Institute for Immunology, La Jolla, CA, USA; Department of Molecular and Clinical Cancer Medicine and NIHR and CRUK Liverpool Experimental Cancer Medicine Center, University of Liverpool, Liverpool, UK.
  • Vijayanand P; La Jolla Institute for Immunology, La Jolla, CA, USA; University of California San Diego, La Jolla, CA, USA; Department of Molecular and Clinical Cancer Medicine and NIHR and CRUK Liverpool Experimental Cancer Medicine Center, University of Liverpool, Liverpool, UK. Electronic address: vijay@lji.org
Cell Rep ; 42(2): 112040, 2023 02 28.
Article en En | MEDLINE | ID: mdl-36701231
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Neoplasias Idioma: En Revista: Cell Rep Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Moléculas de Adhesión Celular / Neoplasias Idioma: En Revista: Cell Rep Año: 2023 Tipo del documento: Article